Applied Therapeutics (APLT) Short Interest Ratio & Short Volume $0.47 +0.02 (+4.54%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$0.46 -0.01 (-2.54%) As of 06:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Applied Therapeutics Short Interest DataApplied Therapeutics (APLT) has a short interest of 9.78 million shares, representing 7.02% of the float (the number of shares available for trading by the public). This marks a -26.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 965,220 shares to cover all short positions.Current Short Interest9,780,000 sharesPrevious Short Interest13,250,000 sharesChange Vs. Previous Month-26.19%Dollar Volume Sold Short$4.40 millionShort Interest Ratio4.7 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares141,580,000 sharesShort Percent of Float7.02%Today's Trading Volume878,664 sharesAverage Trading Volume965,220 sharesToday's Volume Vs. Average91% Short Selling Applied Therapeutics? Sign up to receive the latest short interest report for Applied Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPLT Short Interest Over TimeAPLT Days to Cover Over TimeAPLT Percentage of Float Shorted Over Time Applied Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20259,780,000 shares $4.40 million -26.2%7.0%4.7 $0.45 7/15/202513,250,000 shares $5.60 million -26.7%N/A5.8 $0.42 6/30/202518,080,000 shares $5.62 million -15.2%13.0%7.5 $0.31 6/15/202521,330,000 shares $7.55 million +18.4%15.3%9.9 $0.35 5/31/202518,010,000 shares $6.44 million -9.0%16.9%8.4 $0.36 5/15/202519,790,000 shares $9.71 million +25.0%18.6%8.5 $0.49 4/30/202515,830,000 shares $6.48 million -1.7%N/A7.2 $0.41 4/15/202516,100,000 shares $5.28 million -2.0%15.1%6.6 $0.33 3/31/202516,420,000 shares $8.05 million -9.8%15.4%4.7 $0.49 3/15/202518,200,000 shares $9.34 million -6.8%17.1%4.4 $0.51 Get the Latest News and Ratings for APLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/202519,530,000 shares $9.93 million -0.9%18.4%3.5 $0.51 2/15/202519,710,000 shares $12.75 million -6.5%18.5%2.8 $0.65 1/31/202521,080,000 shares $12.36 million -5.0%N/A3.1 $0.59 1/15/202522,190,000 shares $14.63 million +15.8%N/A3.4 $0.66 12/31/202419,160,000 shares $16.40 million +5.6%N/A3.3 $0.86 12/15/202418,150,000 shares $20.87 million +28.0%N/A3.6 $1.15 11/30/202414,180,000 shares $28.79 million +4.6%N/A2.8 $2.03 11/15/202413,560,000 shares $117.84 million +11.7%N/A4.9 $8.69 10/31/202412,140,000 shares $107.32 million -16.5%N/A4.7 $8.84 10/15/202414,530,000 shares $132.80 million +17.6%N/A5.8 $9.14 9/30/202412,360,000 shares $105.06 million +14.2%N/A5.2 $8.50 9/15/202410,820,000 shares $52.91 million +10.8%N/A4.5 $4.89 8/31/20249,770,000 shares $61.94 million +2.2%N/A7.8 $6.34 8/15/20249,560,000 shares $56.60 million +4.5%N/A8 $5.92 7/31/20249,150,000 shares $54.35 million +0.6%N/A8.2 $5.94 7/15/20249,100,000 shares $54.05 million +44.0%N/A9.3 $5.94 6/30/20246,320,000 shares $29.51 million +9.9%N/A6.4 $4.67 6/15/20245,750,000 shares $29.04 million +34.4%N/A6.9 $5.05 5/31/20244,280,000 shares $18.32 million -6.4%N/A5.1 $4.28 5/15/20244,570,000 shares $20.11 million +2.2%N/A3.9 $4.40 4/30/20244,470,000 shares $19.76 million -5.7%N/A2.6 $4.42 4/15/20244,740,000 shares $23.98 million -4.8%N/A2.6 $5.06 3/31/20244,980,000 shares $33.86 million +31.4%N/A2.4 $6.80 3/15/20243,790,000 shares $22.82 million -12.5%N/A1.8 $6.02 2/29/20244,330,000 shares $30.83 million +11.9%N/A1.9 $7.12 2/15/20243,870,000 shares $14.51 million +4.3%N/A2 $3.75 1/31/20243,710,000 shares $11.61 million +2.2%N/A2.7 $3.13 1/15/20243,630,000 shares $9.08 million +83.3%N/A2.8 $2.50 12/31/20231,980,000 shares $6.63 million -7.5%N/A1.5 $3.35 12/15/20232,140,000 shares $6.33 million -37.1%N/A2.1 $2.96Altucher: It Looks Like My Trump prediction is coming true (Ad)New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.See Altucher’s Trump crypto prediction here 11/30/20233,400,000 shares $7.17 million +71.7%N/A3.2 $2.11 11/15/20231,980,000 shares $4.22 million +2.6%N/A2 $2.13 10/31/20231,930,000 shares $4.63 million +27.0%N/A2.1 $2.40 10/15/20231,520,000 shares $3.68 million +49.0%N/A1.6 $2.42 9/30/20231,020,000 shares $2.54 million -55.5%N/A1.4 $2.49 9/15/20232,290,000 shares $4.26 million +54.7%N/A3.6 $1.86 8/31/20231,480,000 shares $1.97 million -3.3%N/A3.6 $1.33 8/15/20231,530,000 shares $2.05 million +39.1%N/A6.4 $1.34 7/31/20231,100,000 shares $1.96 million No ChangeN/A4.5 $1.78 7/15/20231,100,000 shares $1.52 million +0.9%N/A2.8 $1.38 6/30/20231,090,000 shares $1.40 million +9.1%N/A2.7 $1.28 6/15/2023999,000 shares $1.43 million +13.5%N/A2.4 $1.43 5/31/2023880,000 shares $1.14 million +48.1%N/A2.2 $1.29 5/15/2023594,400 shares $855.94 thousand -18.2%N/A1.5 $1.44 4/30/2023726,400 shares $1.23 million +107.4%N/A1.6 $1.70 4/15/2023350,200 shares $292.77 thousand -21.0%N/A1.1 $0.84 3/31/2023443,300 shares $359.56 thousand +6.3%N/A1.8 $0.81 3/15/2023417,000 shares $371.13 thousand -17.3%N/A1.5 $0.89 2/28/2023504,100 shares $509.14 thousand +32.2%N/A1.8 $1.01 2/15/2023381,300 shares $381.30 thousand -3.3%N/A1.2 $1.00 1/31/2023394,100 shares $437.45 thousand +8.8%N/A1.3 $1.11 1/15/2023362,200 shares $340.47 thousand +70.9%N/A1.2 $0.94 12/30/2022211,900 shares $161.04 thousand -34.3%N/A0.6 $0.76 12/15/2022322,600 shares $275.82 thousand +29.7%N/A0.9 $0.86 11/30/2022248,800 shares $278.66 thousand -6.6%N/A0.7 $1.12 11/15/2022266,400 shares $226.12 thousand +14.4%N/A0.8 $0.85 10/31/2022232,800 shares $180.19 thousand -11.0%N/A0.7 $0.77 10/15/2022261,500 shares $161.08 thousand +24.8%N/A0.8 $0.62 9/30/2022209,600 shares $194.95 thousand -1.1%N/A0.8 $0.93 9/15/2022212,000 shares $313.76 thousand -9.4%N/A0.5 $1.48 8/31/2022234,000 shares $320.58 thousand -2.3%N/A0.5 $1.37 8/15/2022239,600 shares $328.25 thousand -25.6%N/A0.5 $1.37 7/31/2022322,200 shares $347.98 thousand -24.0%N/A0.8 $1.08 7/15/2022424,100 shares $436.82 thousand -83.2%N/A1 $1.03 6/30/20222,520,000 shares $2.39 million +88.1%N/A6 $0.95 6/15/20221,340,000 shares $1.47 million -2.2%7.8%4.4 $1.10 5/31/20221,370,000 shares $1.97 million +3.8%8.0%6 $1.44 5/15/20221,320,000 shares $2.27 million -20.0%7.7%5.6 $1.72 4/30/20221,650,000 shares $3.25 million -12.7%11.1%6.6 $1.97 4/15/20221,890,000 shares $3.89 million -1.1%12.7%6.7 $2.06 3/31/20221,910,000 shares $4.03 million +7.9%12.9%6.5 $2.11 3/15/20221,770,000 shares $2.69 million +22.9%N/A4.6 $1.52 2/28/20221,440,000 shares $2.71 million +12.5%9.7%4.1 $1.88 2/15/20221,280,000 shares $2.91 million +23.1%8.6%3.8 $2.27 1/31/20221,040,000 shares $3.20 million +24.6%6.9%3.3 $3.08 1/15/2022834,900 shares $3.29 million -21.2%5.7%3.1 $3.94 12/31/20211,060,000 shares $9.49 million +1.0%7.1%4.3 $8.95 12/15/20211,050,000 shares $10.12 million +2.9%7.0%11.5 $9.64 11/30/20211,020,000 shares $11.71 million +2.0%6.7%10.8 $11.48 11/15/20211,000,000 shares $14.17 million -5.7%6.5%10.6 $14.17Altucher: It Looks Like My Trump prediction is coming true (Ad)New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.See Altucher’s Trump crypto prediction here 10/29/20211,060,000 shares $15.55 million +1.9%6.9%11 $14.67 10/15/20211,040,000 shares $17.77 million -10.3%6.8%11.3 $17.09 9/30/20211,160,000 shares $19.26 million -3.3%7.6%13.3 $16.60 9/15/20211,200,000 shares $17.82 million +0.8%7.8%12.9 $14.85 8/31/20211,190,000 shares $18.69 million -10.5%7.8%13.9 $15.71 8/13/20211,330,000 shares $21.36 million -6.3%8.7%14.8 $16.06 7/30/20211,420,000 shares $24.44 million -1.4%9.3%15.5 $17.21 7/15/20211,440,000 shares $28.02 million +0.7%8.2%15.7 $19.46 6/30/20211,430,000 shares $29.72 million No Change8.2%15.4 $20.78 6/15/20211,430,000 shares $33.81 million -4.7%8.2%16.6 $23.64 5/28/20211,500,000 shares $28.85 million -5.1%8.6%16.6 $19.23 5/14/20211,580,000 shares $22.40 million +5.3%N/A15.3 $14.18 4/30/20211,500,000 shares $27.54 million -2.0%N/A12.6 $18.36 4/15/20211,530,000 shares $25.41 million -4.4%9.0%11.9 $16.61 3/31/20211,600,000 shares $29.38 million +6.0%N/A12.2 $18.36 3/15/20211,510,000 shares $29.40 million +22.8%N/A10.8 $19.47 2/26/20211,230,000 shares $28.20 million -24.1%7.3%8.9 $22.93 2/12/20211,620,000 shares $37.88 million +8.7%10.3%11.7 $23.38 1/29/20211,490,000 shares $32.06 million -2.6%10.9%10.8 $21.52 1/15/20211,530,000 shares $33.34 million -1.3%11.1%11 $21.79 12/31/20201,550,000 shares $33.46 million -1.3%11.3%11.3 $21.59 12/15/20201,570,000 shares $37.92 million +6.1%11.4%10.9 $24.15 11/30/20201,480,000 shares $34.78 million -12.9%11.2%10.1 $23.50 11/15/20201,700,000 shares $27.90 million +3.7%12.9%11.9 $16.41 10/30/20201,640,000 shares $27.98 million +17.1%12.5%11.7 $17.06 10/15/20201,400,000 shares $33.18 million -13.0%10.7%9.5 $23.70 9/30/20201,610,000 shares $33.42 million +6.6%12.3%8.4 $20.76 9/15/20201,510,000 shares $36.19 million No Change11.5%6.3 $23.97 8/31/20201,510,000 shares $36.39 million -4.4%11.5%6.2 $24.10 APLT Short Interest - Frequently Asked Questions What is Applied Therapeutics' current short interest? Short interest is the volume of Applied Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 9,780,000 shares of APLT short. 7.02% of Applied Therapeutics' shares are currently sold short. Learn More on Applied Therapeutics' current short interest. What is a good short interest ratio for Applied Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APLT shares currently have a short interest ratio of 5.0. Learn More on Applied Therapeutics's short interest ratio. Which institutional investors are shorting Applied Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Applied Therapeutics: Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Applied Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.02% of Applied Therapeutics' floating shares are currently sold short. Is Applied Therapeutics' short interest increasing or decreasing? Applied Therapeutics saw a drop in short interest in July. As of July 31st, there was short interest totaling 9,780,000 shares, a drop of 26.2% from the previous total of 13,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Applied Therapeutics' short interest compare to its competitors? 7.02% of Applied Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Applied Therapeutics: Bright Minds Biosciences Inc. (4.13%), Galectin Therapeutics Inc. (17.76%), Aurora Cannabis Inc. (10.10%), Larimar Therapeutics, Inc. (8.06%), Allogene Therapeutics, Inc. (12.88%), Aerovate Therapeutics, Inc. (21.72%), Design Therapeutics, Inc. (11.27%), Adherex Technologies Inc. (5.56%), Alpha Teknova, Inc. (28.00%), ProQR Therapeutics N.V. (0.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Applied Therapeutics stock? Short selling APLT is an investing strategy that aims to generate trading profit from Applied Therapeutics as its price is falling. APLT shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Applied Therapeutics? A short squeeze for Applied Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APLT, which in turn drives the price of the stock up even further. How often is Applied Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLT, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Bright Minds Biosciences Short Interest Galectin Therapeutics Short Interest Aurora Cannabis Short Interest Larimar Therapeutics Short Interest Allogene Therapeutics Short Interest Aerovate Therapeutics Short Interest Design Therapeutics Short Interest Adherex Technologies Short Interest Alpha Teknova Short Interest ProQR Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APLT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access